Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | IDO1 | P14902 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.61 |
| ▸ | HTR3B | O95264 | 2/20 | 0.61 |
| ▸ | HTR3A | P46098 | 2/20 | 0.61 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.61 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | TYR | P14679 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11449848 | 0.89 | IDO1 (0.70) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL4047674 | 0.85 | KMT2A (0.76) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL10481432 | 0.84 | IDO1 (0.62) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL22274845 | 0.84 | IDO1 (0.73) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL26991 | 0.83 | IDO1 (0.79) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL29481122 | 0.83 | IDO1 (0.79) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL11449846 | 0.83 | IDO1 (0.66) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL11260245 | 0.82 | IDO1 (0.65) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL9690067 | 0.81 | GAA (1.00) | GAAALDH1A1MAPTIDO1KMT2A | |
| SCHEMBL5437433 | 0.81 | IDO1 (1.00) | GAAALDH1A1MAPTIDO1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114432901-B | Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-114432901-A | Composite membrane with acid resistance and alkali resistance as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| JP-55000344-A | — | — | None | — | — | JP | disclosed |
| US-20250092020-A1 | IDO/TDO Inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-03-20 | — | — | US | disclosed |
| US-12209079-B2 | IDO/TDO inhibitor | GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) | 2025-01-28 | — | — | US | disclosed |
| US-20250011315-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | PRISM MEDICINES, INC. | 2025-01-09 | — | — | US | disclosed |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240165983-A1 | DRAWING SYSTEM AND DRAWING METHOD | Sony Group Corporation (JP) | 2024-05-23 | — | — | US | disclosed |
| US-20230295147-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | ARYL THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
| CN-1035253-C | Pyranyl cyanoguanidine derivatives | SQUIBB & SONS INC (US) | 1997-06-25 | — | — | CN | disclosed |
| EP-0666507-A2 | Negative charging type printing photosensitive resin composition | Nippon Paint Co., Ltd. (JP) | 1995-08-09 | — | — | EP | disclosed |
| CN-1064272-A | PYRANYL CYANOGUANIDINE DERIVATIVES | SQUIBB & SONS INC (US) | 1992-09-09 | — | — | CN | disclosed |
| US-4713382-A | N-phenyl-4-phenyl-1-piperazinecarboxamidines and related compounds as antiarrhythmic agents | SYNTEX (U.S.A.) INC. (US) | 1987-12-15 | — | — | US | disclosed |
| CN-86103798-A | The preparation method of N-phenyl-4-phenyl-1-piperazine carbonamidine and their purposes as anti-arrhythmic | — | 1987-06-10 | — | — | CN | disclosed |
| EP-0204265-A1 | N-Phenyl-4-phenyl-1-piperazine carboxamidines and related compounds as antiarrhythmic agents | LABORATOIRES SYNTEX S.A. (FR) | 1986-12-10 | — | — | EP | disclosed |
| US-4252963-A | CYCLIZATION OF PHENYLTHIOUREAS WITH THIONYL CHLORIDE | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | disclosed |
| US-4225591-A | CORONARY VASODILATOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-09-30 | — | — | US | disclosed |
| JP-S55344-A | 2-NITROSOIMINOBENZTHIAZOLINE DERIVATIVE | IWAKI SEIYAKU KK | 1980-01-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12209079-B2 | IDO/TDO inhibitor | IDO1, IDO2, TDO2 | GAA 3551/4885ALDH1A1 3331/4885MAPT 609/4885 |
| US-20250011315-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | AHR, ARNT, HCAR1 | GAA 3146/4885ALDH1A1 289/4885MAPT 4673/4885 |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | AHR, ARNT, HCAR1 | GAA 3146/4885ALDH1A1 289/4885MAPT 4673/4885 |
| US-20230295147-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | AHR, ARNT, HCAR1 | GAA 3146/4885ALDH1A1 289/4885MAPT 4673/4885 |
| US-20250092020-A1 | IDO/TDO Inhibitor | IDO1, IDO2, TDO2 | GAA 3551/4885ALDH1A1 3331/4885MAPT 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.